Improving the development and health of highly vulnerable patient populations
Increasing the understanding of disease processes and identifying novel neuroprotective treatment strategies
Contributing with internationally highly competitive research and fostering distinguished and competent scientist
Föregående bild
Nästa bild

About Us

The overall objective of the Neonatal Neuroprotection group is to identify and evaluate novel neuroprotective interventions to improve development and health in extremely vulnerable clinical populations.

From a clinical perspective, our research focus on three main groups of infants:

  • Infants born extremely preterm,
  • Infants who develop severe cerebral intraventricular hemorrhage, and
  • Infants with severe congenital heart defects requiring surgery assisted by cardiopulmonary bypass

Through our research, we aim to:

  • Build an increased understanding of the processes responsible for the development of brain damage and subsequent neurological and cognitive impairment
  • Identify novel protective treatment strategies in order to improve neurodevelopment

Latest News

Collaboration with Spädbarnsfonden

We are pleased to share that our research group is collaborating with Spädbarnsfonden. This partnership marks a significant step in our ongoing efforts to contribute to vital research in neonatal care and development.

For more information about Spädbarnsfonden, please visit: https://www.spadbarnsfonden.se/forskningsnamnden/

Interview published

In a recent interview by the Faculty of Medicine at Lund University, our researchers Niklas Ortenlöf and Magnus Gram discuss their research related to Niklas’s doctoral thesis, shedding light on important aspects of neonatal brain development.

Read the full interview here: https://www.medicin.lu.se/artikel/viktig-transportvag-i-den-omogna-hjarnan-hos-tidigt-fodda

Evaluation of recombinant human IGF-1/IGFBP-3 on intraventricular hemorrhage prevention and survival in the preterm rabbit pup mode

Authors:  Claes Ekström, Niklas Ortenlöf, Amanda Kristiansson, Bo Holmqvist, Åsa Jungner, Suvi Vallius, Xiaoyang Wang, Ann Hellström, Norman Barton, Galen Carey, David Ley & Magnus Gram. Biomolecules.  2023;13, 19847

Full text: https://www.nature.com/articles/s41598-023-46611-0?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20231114&utm_content=10.1038/s41598-023-46611-0